- Recommendation ID
- Imaging modalities for monitoring response and recurrent disease:- Randomised controlled trials should be conducted to examine the value of imaging modalities and other interventions in the monitoring of response and recurrent disease.
- Any explanatory notes
- Why this is important:- Patients with lung cancer have high recurrence rates even when treated with curative intent. It is not known whether imaging modalities and other interventions in the follow-up period can improve outcomes by detecting recurrence or relapse earlier. Therefore no firm recommendations can be made about their scheduling or use. This question should be addressed through properly designed clinical trials.
Source guidance details
- Comes from guidance
- Lung cancer: diagnosis and management
- Date issued
- April 2011
|Is this a recommendation for the use of a technology only in the context of research?||No|
|Is it a recommendation that suggests collection of data or the establishment of a register?||No|